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Introduction: Currently, there is not enough data available concerning sepsis in developing countries, 
especially in Latin America. 
Objective: We developed a study aimed at determining the frequency, clinical and epidemiological 
characteristics, and the consequences of sepsis in patients requiring admission to intensive care units 
in Colombia. 
Materials and methods: This was a secondary analysis of a prospective cohort study carried out over 
a six-month period, from September 1, 2007, to February 28, 2008, in ten medical/surgical intensive 
care units in four Colombian cities. Patients were considered eligible if they had a probable or confirmed 
diagnosis of infection according to medical records. We recorded demographic characteristics, first 
admission diagnosis and co-morbidities, clinical status, and sepsis, severe sepsis or septic shock. 
Results: During the study period, 826 patients were admitted to the intensive care units. From these 
patients, 421 (51%) developed sepsis in the community, 361 (44%) in the ICU, and 44 (5%) during 
hospitalization in the general ward. Two hundred and fifty three patients (30.6%) had involvement of 
one organ system: 20% had respiratory involvement, followed by kidney and central nervous system 
involvement with 3.4% and 2.7%, respectively. 
Conclusions: In our cohort of septic patients, the prevalence of sepsis treated in ICU is similar to that 
reported in other studies, as well as the overall mortality.
Key words: Sepsis/epidemiology; septic shock; intensive care. 
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Epidemiología de la sepsis en unidades de cuidado intensivo en Colombia
Introducción. Actualmente no se cuenta con muchos datos disponibles sobre la sepsis en los países 
en desarrollo y especialmente en América Latina. 
Objetivo. Este estudio tuvo como objetivo determinar la frecuencia, las características clínicas y 
epidemiológicas y las consecuencias de la sepsis en una población de pacientes que requirieron 
ingreso en algunas unidades colombianas de cuidados intensivos.
Materiales y métodos. Este fue un análisis secundario de un estudio prospectivo realizado en un 
período de seis meses contados a partir del 1° de septiembre de 2007 hasta el 28 de febrero del 
2008 en diez unidades médico-quirúrgicas de cuidados intensivos de cuatro ciudades de Colombia. Los 
pacientes se consideraron elegibles si tenían un diagnóstico probable o confirmado de infección según 
los registros médicos. Se registraron las características demográficas, los diagnósticos de primer ingreso 
y las enfermedades concomitantes, el estado clínico y la sepsis, sepsis grave o choque séptico.
Resultados. Durante el período de estudio, 826 pacientes fueron ingresados en las unidades de 
cuidados intensivos seleccionadas para el estudio. De estos pacientes, 421 (51 %) desarrollaron 
sepsis en la comunidad, 361 (44 %) en la unidad de cuidados intensivos y 44 (5 %) durante la 
hospitalización en la sala general; 253 pacientes (30,6 %) presentaron afectación de un órgano 
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del sistema: 20 % tuvo problemas respiratorios, seguido por problemas en los riñones y el sistema 
nervioso central con 3,4 % y 2,7 %, respectivamente.
Conclusiones. En la muestra de pacientes sépticos, la prevalencia de la sepsis, así como de 
la mortalidad global, en los pacientes tratados en la unidad de cuidados intensivos fue similar a la 
reportada en otros estudios.
Palabras clave: sepsis/epidemiología, choque séptico, cuidados intensivos. 
doi: http://dx.doi.org/10.7705/biomedica.v34i1.1439
Severe sepsis and septic shock are important 
causes of morbidity and mortality in patients 
admitted to intensive care units. These conditions 
are generally associated with multiple organ failure 
as final outcome (1-5). Over the past 30 years, 
the worldwide incidence of sepsis has increased 
by 13.7% per year (1-5). It is therefore estimated 
that more than 18 million people suffer from sepsis 
each year and more than five million of them die 
(1-5). This increase is arguably due to increasing 
numbers of people aged over 65 years (60% of 
septic patients are more than 65 years old), to 
more frequent diseases and therapies causing 
immunosuppression, and to widespread use of 
diagnostic and/or therapeutic invasive procedures.
Despite important advances in the understanding of 
the pathophysiology of sepsis, its overall mortality 
is greater than 30% (1-5). These data come from 
studies carried out in developed countries. Although 
most of the world’s population lives in developing 
countries, very few studies assessing the frequency 
and mortality of sepsis in these nations are 
available. Mortality reports from Pakistan, Thailand, 
and Turkey range from 80 to 92% for severe sepsis 
(6-8). These and other publications suggest that 
mortality due to sepsis is much higher in developing 
countries than in developed ones (6-9).
Enough evidence substantiates the fact that sepsis 
is associated with increased consumption of 
resources. Moreover, it prolongs hospital stays in 
both the intensive care unit (ICU) and the general 
ward (9). The estimated cost of treating patients 
with severe sepsis is about 17 billion dollars per 
year in the United States (1-5); therefore, the 
hospital care cost of a patient with severe sepsis 
is about 10.000 dollars (1-9). In Colombia there are 
no data allowing calculation of the costs of sepsis 
for our health system.
Until recently, treatment for septic patients was 
limited to antibiotic therapy. In recent years, clinical 
studies have shown improved outcomes due to 
therapies such as early goal-directed therapy 
(10), low-dose steroids (11), and drotrecogin alpha 
(activated) (12). Observational studies have shown 
that early, adequate instauration of antibiotic therapy 
can improve the survival rates of these patients 
(13). Moreover, it has been shown that some 
interventions can prevent conditions associated 
with the development of sepsis, such as ventilator-
associated pneumonia and intravascular device-
associated sepsis (14). It is of critical importance 
to determine the incidence, the prevalence, and 
the outcomes of severely ill septic patients in 
order to calculate the resources required for the 
management of septic patients in intensive care 
units, as well as to implement strategies aimed at 
improving their outcome.
In view of the paucity of information concerning 
sepsis in developing countries, and especially 
in Latin America, we have developed a study 
aimed at determining the frequency, the clinical 
and epidemiological characteristics, and the 
consequences of sepsis in a population of patients 
requiring admission to the intensive care units of 
ten Colombian reference hospitals.
Materials and methods
This is a secondary analysis of a prospective cohort 
study carried out over a period of six months, 
from September 1, 2007 to February 28, 2008, 
in 10 medical/surgical intensive care units in four 
Colombian cities among patients admitted to the ICU. 
These units have an average availability of 274 beds 
per month. Patients were considered eligible if they 
were older than 18 years; had a probable or confirmed 
diagnosis of infection according to medical records, 
or had changes in temperature (>38 °C or < 36 °C) or 
hypotension without a specific cause. Furthermore, 
as definitive inclusion criterion, patients must have 
had an infection fulfilling standard CDC definitions 
(15). Patients were excluded if they refused to 
participate, were screened for eligibility more than 24 
hours after suspicion of infection, stayed more than 
Corresponding author:
Guillermo Ortíz, Calle 105 N° 23-30, apartamento 402, Bogotá, 
D.C., Colombia
Teléfono: (571) 602 8675
ortiz_guillermo@hotmail.com
Recibido: 09/11/12; aceptado: 26/07/13
42
Biomédica 2014;34:40-7Ortíz G, Dueñas C, Rodríguez F, et al.
48 hours in another institution immediately before the 
current hospitalization, were not available for 28-day 
follow-up, or were discharged less than 24 hours after 
hospitalization or their diagnosis changed toward a 
non-infectious disease during hospitalization. The 
study protocol was approved by the institutional 
review board at each center. Oral informed consent 
was obtained in all hospitals except in two where 
written informed consent was requested. Data from 
patients requiring admission to ICU due to infection 
were taken into account. The need for hospital and 
ICU admission was decided by the medical team 
responsible for the patient and it was independent of 
the research group.
There were one or two trained nurses according to 
the number of beds in each hospital. They followed 
a study protocol standardized twice in two-day 
workshops developed within a three-month pilot 
study which was conducted immediately before 
starting the recruitment. In each hospital there 
was also a co-investigator clinician in charge of 
checking data accuracy and consistency, as well as 
the patient´s diagnosis. In addition, the case report 
forms (CRF) were checked and revised weekly 
in a double-entry form in the Data Coordinating 
Center (DCC, Universidad de Antioquia). Any 
inconsistency, inaccuracy or missing data implied 
returning the specific CRF to the co-investigator 
for correction within the next week after the DCC 
review. There was also on-site evaluation during 
the first month of the study at each hospital by one 
of the principal co-investigators. 
The severity of illness was assessed using the 
Acute Physiologic and Chronic Health Evaluation 
II (APACHE II) score, and the frequency and 
magnitude of organ dysfunction was measured 
with the Sequential Organ Failure Assessment 
(SOFA) score, both determined within the first 24 
hours after enrollment of the patient. We recorded 
also demographic characteristics, first admission 
diagnosis and comorbidities, clinical status 
as sepsis, severe sepsis or septic shock, any 
microbiological report and antibiogram during the 
first seven days after enrollment, and vital status at 
hospital discharge. Patients were evaluated daily 
during their hospital stay. For patients discharged 
before 28 days, their vital status was confirmed by 
phone call or outpatient control.
Results are expressed as mean and standard 
deviation (SD), median and interquartile range (IQR), 
or proportions according to the type and distribution 
of the variable. Patients were analyzed in three 
groups according to where their sepsis developed: 
patients who developed sepsis in the community, 
patients who developed sepsis in the general ward, 
and patients who developed sepsis in the ICU. There 
was not a formal calculation of sample size given 
the expected variability in the frequency of sepsis 
and severe sepsis within and among hospitals. The 
database was recorded in Access (Microsoft Office, 
USA, 2007) and all the statistical analyses were 
performed with STATA (State corp, Release 10, 
College Station, TX, USA).
Results
Demographic data
During the study period, 6,768 patients were 
admitted to the ten ICU, of whom 826 (12%) were 
diagnosed with sepsis. Of these patients, 421 (51 
%) developed sepsis in the community, 361 (44%) 
in the ICU, and 44 (5%) during hospitalization 
in the general ward. The average age of the 
population under study was 54.5 ± 20 years, with 
predominance of the male gender (53%). There 
were no significant differences with regard to age or 
gender among the three groups of patients. Mean 
APACHE II scores were different among the three 
groups at the moment of diagnosis. The group 
that developed sepsis in the ICU had the lowest 
score and SOFA scores behaved likewise. Latin 
American patients were the most common, with 
90.5% of cases. Table 1 summarizes the general 
characteristics of the patients. The most frequent 
comorbidities were: previous surgery or trauma 
(48%), chronic obstructive pulmonary disease, 
heart failure, and diabetes (13% each) (table 2). 
Within the total population, the primary diagnosis 
of infection was intra-abdominal infection in 18.6% 
of cases, followed by hospital acquired pneumonia, 
and community-acquired pneumonia, with 17% 
and 12.4%, respectively. Other types of infection 
are listed in table 3.
Severity of infection
Out of the 826 patients admitted to the ICUs, 12% 
(n=97) had no organ involvement. Two hundred 
and fifty three patients (30.6%) had involvement 
of one organ system: 20% had respiratory 
involvement, followed by kidney and central 
nervous system involvement with 3.4% and 
2.7%, respectively. Two hundred and forty five 
patients (29.6%) had involvement of two organs, 
16% (n=132) had involvement of three organs, 
8.5% (n=70) had involvement of four organs, 
and 3% (n=25) had involvement of five organs 
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on admission. Table 4 shows the classification 
of patients according to the severity of infection. 
For the population under study, the frequency of 
severe sepsis without shock on the first day of the 
follow-up was 53.2%.
Microbiology
In total, 1,133 samples were taken for bacterial 
cultures: blood (n = 449, 40%), urine (n= 290, 26%), 
sputum (n= 162, 14%), peritoneal fluid (n = 105, 9.3%) 
and other (n=127, 11.2%). Gram-negative bacilli 
were the most frequently isolated microorganisms 
(n=360 isolations). Table 5 shows the predominant 
isolations according to type of sample.
Outcomes
Day-28 mortality of patients admitted to the ICU 
with sepsis but with no organ dysfunction was 
19.4%. It was higher in patients diagnosed with 
septic shock (45.1%) than in patients with sepsis 
Table 1. Demographic characteristics of patients with sepsis who required management in the intensive care units
Community
n=422 (51%)
Intensive care units 
n=360 (44%)
Hospital wards
n=44 (5%)
Age, mean ± SD
Male gender (%)
Latin American origin (%)
SOFA, mean ± SD
Apache II, mean ± SD
Median hospital stay (days)
56.2 ± 20
51.7
94.1
6.47 ± 3.7
16.2 ± 6.8
12
52.1 ± 20
53.1
85.6
5.60 ± 3.1
13.7 ± 6.4
24
58.3 ± 18.8
56.8
97.7
6.3 ± 3.4
15.3 ± 6.5
10.6
SD: Standard deviation
Table 2. Comorbidities of patients managed in the intensive care units*
Comorbidities Community
n=422 (%)
Intensive care units
n=360 (%)
Hospital wards
n=44 (%)
Trauma or surgery
None
Chronic obstructive pulmonary disease
Congestive heart failure
Diabetes mellitus
Chronic renal failure
History of cancer during the last year
Use of steroids
Drug addiction/alcoholism
Organ transplantation
HIV/AIDS
Cirrhosis
128 (30.3)
119 (28.2)
57 (13.5)
63 (14.9)
65 (15.4)
51 (12.1)
40   (9.5)
33   (7.8)
23   (5.4)
16   (3.8)
10   (2.4)
6   (1.4)
230 (63.9)
57 (15.8)
44 (12.2)
40 (11.1)
38 (10.5)
45 (12.5)
22   (6.1)
14   (3.9)
15   (4.2)
7   (1.9)
1   (0.3)
6   (1.7)
20 (45.4)
6 (13.6)
8 (18.2)
6 (13.6)
6 (13.6)
9 (20.4)
2   (4.5)
4   (9.1)
2   (4.5)
0   
2   (4.5)
0
*Some patients may have more than one.
Table 3. Diagnosis of infection in patients with sepsis managed in the intensive care units
Main infection Community
n=422 (%)
Intensive
care units
n=360 (%)
Hospital
wards
n=44 (%)
Intraabdominal infection
Hospital-acquired pneumonia
Community-acquired pneumonia
Symptomatic urinary tract infection
Clinical sepsis
Soft-tissue infections
Bloodstream infection
Catheter-associated urinary tract infection
Bacteremia associated with arterial or central venous catheter
Meningitis or ventriculitis
Intracranial infection
Endocarditis
Mediastinitis
Other infections of the urinary tract
Other
84 (19.9)
1   (0.2)
103 (24.4)
55 (13.0)
35   (8.3)
47 (11.1)
17   (4.0)
4   (0.9)
4   (0.9)
13   (3.1)
14   (3.3)
13   (3.1)
8   (1.9)
5   (1.2)
19   (4.5)
63 (17.5)
119 (33.1)
0
40 (11.1)
40 (11.1)
11   (3.1)
33   (9.2)
16   (4.4)
13   (3.6)
4   (1.1)
1   (0.3)
1   (0.3)
0
4   (1.1)
15   (4.2)
3   (6.8)
21 (47.7)
0
1   (2.3)
2   (4.5)
2   (4.5)
1   (2.3)
4   (9.1)
0
0
0
0
1   (2.3)
0
9 (20.5)
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but without shock (27.5%). The overall mortality 
rate at the time of discharge was 33.6%.
Discussion
Sepsis is an important cause of morbidity and 
mortality in our intensive care units. In recent years, 
clinical studies assessing interventions aimed at 
the management of sepsis have reported benefits 
concerning the mortality of critically ill patients (10-
13). In Colombia, however, there are no general 
data that allow us to calculate the true impact of 
sepsis in critically ill patients.
The results of our study are important for the 
following reasons: The prevalence of septic 
patients treated in the ICU was similar to that 
reported in other studies (16-19), as well as the 
overall mortality. However, it was greater than that 
observed in some treatment arms of clinical studies 
(12). This can be analyzed as an opportunity to 
intervene such pathological condition. 
These data are highly important in order to calculate 
the impact of sepsis on the health system, to 
assess the risk stratification of patients admitted to 
hospitals with a diagnosis of sepsis, and for future 
clinical studies. Recent studies from Europe, the 
United Kingdom, Australia, and New Zealand have 
shown the incidence rates of sepsis and its mortality 
in the ICU (16-20). North American studies are 
limited to data obtained in four Canadian intensive 
care units that participated in a multinational study 
(Alberti), or taken from administrative databases 
(1). These data revealed an incidence of sepsis in 
the ICU ranging from 11.8 to 37.4%, with mortality 
between 35 and 53.6% (both in the hospital and 
after 30 days). A prospective study carried out in 
eight academic medical centers in the United States 
revealed an incidence of sepsis in 2% of all hospital 
admissions and 59% of ICU admissions (21).
Sepsis, severe sepsis, and septic shock are 
more frequent in the ICU than in other sections 
of a healthcare institution (22-25). Several reports 
have confirmed that severe sepsis is found in 2% 
of patients admitted to the general ward, while it 
is found in up to 75% of ICU patients (18, 20, 26, 
27). It is logical to consider that severely ill, infected 
patients should be admitted to the ICU, and this can 
partly explain the high frequency of sepsis in the 
Table 4. Number of patients with sepsis, severe sepsis, and septic shock from day 1 to day 7 of their stay at the intensive care unit 
Patient classification Day of follow-up
1
n (%)
2
n (%)
3
n (%)
4
n (%)
5
n (%)
6
n (%)
7
n (%)
Infection without sepsis
Sepsis without organ dysfunction
Severe sepsis without shock
Septic shock
Total number of patients
5   (0.6)
62   (7.5)
440 (53.3)
319 (38.6)
826
18   (2.2)
118 (14.7)
384 (47.9)
281 (35.1)
801
16   (2.1)
142 (18.3)
405 (52.2)
212 (27.3)
775
21   (2.9)
158 (21.7)
394 (54.0)
156 (21.4)
729
27   (3.9)
153 (22.3)
388 (56.6)
117 (17.1)
685
39   (5.9)
147 (22.4)
374 (56.9)
97 (14.8)
657
46   (7.4)
146 (23.5)
354 (57.0)
75 (12.1)
621
Table 5. Number of isolations and samples gathered from patients with sepsis admitted to intensive care units
Community
n=548 
Intensive
care units 
n=536 
Hospital
n=49 
Microorganisms isolated by cultures: 
Total (%)
Gram-negative
Gram-positive
Fungi
223 (41.0)
145 (65.0)
68 (30.5)
10    (4.5)
300 (56)
203 (68)
89 (30)
8   (2)
27 (55)
20 (74)
7 (26)
0
Samples with positive isolations:
Requested, positive (%) 
Blood cultures
Urine cultures
Sputum
Peritoneal fluid
Cerebrospinal fluid
Skin and soft tissues
Other
235.85 (36)
150.63 (42)
  54.24 (44)
  48.26 (54)
     16.2   (12.5)
  16.9   (56)
  29.14 (48)
192.89 (46)
127.68 (53)
104.74 (71)
  55.41 (74)
  17.2   (12)
  13.10 (77)
  28.16 (57)
  22.9   (41)
  13.8   (61)
    4.3   (75)
    2.2 (100)
        2        (0)
    2.2 (100)
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ICU. However, Esteban (28) recently showed that 
most of these patients are treated outside the ICU 
(323 cases/100.000 residents vs. 44 cases/100.000 
residents). Mortality outside the ICU was regrettably 
much higher, up to 53% (28). This has been 
confirmed by other reports (29-35), and it strongly 
suggests that all patients with severe sepsis and 
septic shock should be admitted to the ICU.
On the other hand, the high rates of acquisition of 
infection and development of severe sepsis found 
within hospitals and intensive care units reinforce 
the pressing need for aggressive measures aimed 
at preventing the development of hospital-acquired 
diseases. This means that, besides complying 
with the therapeutic options recommended by the 
sepsis survival campaign (23 y 24), pains must 
be taken to develop strategies aimed at reducing 
catheter-associated infection, ventilator-associated 
pneumonia, and infection of operatory site (23).
Based on administrative data from 1995, Angus 
estimated that the incidence, the mortality, and 
the consumption of resources for sepsis would 
increase by 1.5% per year (1). More recent studies 
have estimated annual increases of up to 10% 
(36, 37). Gender, diabetes, immunosuppression, 
and cancer are among the factors associated 
with these increases. It is therefore arguable that 
the frequency of sepsis and its impact on clinical 
outcomes will continue to increase (38-45). On 
the other hand, statistics can vary according to 
the criteria by which diseases are defined from an 
epidemiological standpoint (46, 47). These data 
become even more important when related to our 
results, since most of our patients were admitted to 
the ICU directly from the community (51%), while 
an important percentage developed sepsis during 
their stay in the ICU (44%), and only a small number 
were admitted from the general wards (5%).
The overall mortality rate at discharge in our study 
was 33.6%. This fits within the ranges reported 
by recent clinical studies that included patients 
diagnosed with severe sepsis. The mortality 
reported for the control groups of the early goal-
oriented therapy study was 47% (10), whereas 
that found in the PROWESS study was 57% (12), 
and that found in the steroid studies was 31% (11), 
while the mortality rates of the intervention groups 
were 31, 47, and 25%, respectively. The differences 
found among the studies could be explained by their 
design characteristics and inclusion and exclusion 
criteria, as well as by the fact that mortality was 
measured at different moments (in the ICU, on the 
28th day, or at hospital discharge). The differences 
between our findings and the control groups of the 
clinical studies could represent a good opportunity 
for intervening on these patients. This is especially 
true if we take into account recent studies assessing 
successful therapeutic interventions in patients with 
severe sepsis and septic shock (48-52).
We think that this study has some strong aspects. 
Among these, we would like to highlight the fact 
that the determination of infection, sepsis, severe 
sepsis, and septic shock was done prospectively, 
according to the CDC and Survival Sepsis 
Campaign definitions. Moreover, several healthcare 
centers from four Colombian cities participated, 
which allowed inclusion of both medical and surgical 
patients, as well as details concerning demographic 
characteristics, comorbidities, severity scores, 
and site of infection of each patient with a central 
coordination at every participating healthcare 
center. Among the limitations of our study, we 
have to mention the fact that the inclusion of the 
healthcare centers was voluntary, which limits our 
ability to generalize its results.
In conclusion, we have shown a prospective record 
of patients with sepsis, severe sepsis, and septic 
shock who were admitted to 10 medical/surgical 
intensive care units in four Colombian cities. We 
determined a prevalence of sepsis of 10.8% and 
an overall mortality of 33.6%. We pointed out the 
importance of the place where the infection was 
acquired for the detection of this group of patients, 
as well as the development of adequate and timely 
therapeutic strategies. These observations are 
useful for improving the quality of septic patients 
care, as well as for the development of future 
clinical studies. 
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